Scientists at MIT have developed nanoparticles that could eliminate the need to use viruses to edit genes.
The past week brought new insights into how beige fat cells burn glucose, a particular protein foretells Alzheimer's and bacteria evade antibiotics.
The complex and intertwined dual epidemics of poorly treated pain and opioid addiction require a combined, artful approach to secure the best possible results…
Worm models show that a previously dismissed process in genetic coding could explain why quitting smoking is so hard.
A new pathway could be exploited to improve the efficacy of GLP-1 agonists in treating diabetes.
Scientists from the University of Chicago and Mount Sinai are exploring different methods of improving checkpoint-inhibiting cancer drugs.
Part of an international initiative, a pan-European observational study aims to improve clinical care of traumatic brain injury.
The past week brought a link between glucose metabolism and Alzheimer's, discovery of two proteins key to TB, and a grant for male contraception.
Researchers in the U.K. tested AstraZeneca’s PARP inhibitor Lynparza and found it can penetrate the blood-brain barrier and invade glioblastoma tumors.
Scientists have discovered key stem cells that help the gecko tail regenerate—insights that may spur therapies for people with spinal cord injuries.
Cord blood, approved for the treatment of some blood disorders, could lead to a new treatment for cerebral palsy.